LNTH Q4 2023 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$6B

Q4 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$354M+34.5% YoY

Gross Profit

$230M64.9% margin

Operating Income

$137M38.8% margin

Net Income

$103M29.2% margin

EPS (Diluted)

$1.47

QoQ Revenue Growth

+10.6%

Cash Flow

Operating Cash Flow

$112M

Free Cash Flow

$100M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$835M

Stockholders' Equity

$816M

Cash & Equivalents

$714M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$354M	$263M	+34.5%
Gross Profit	$230M	$167M	+37.5%
Operating Income	$137M	-$172M	+180.1%
Net Income	$103M	-$119M	+186.7%